These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 36157263)

  • 1. Association of Immune-Related Genetic and Epigenetic Alterations with Lupus Nephritis.
    Mei X; Jin H; Zhao M; Lu Q
    Kidney Dis (Basel); 2022 Jul; 8(4):286-296. PubMed ID: 36157263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An update on genetic susceptibility in lupus nephritis.
    Song K; Liu L; Zhang X; Chen X
    Clin Immunol; 2020 Jun; 215():108389. PubMed ID: 32245575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An update on genetic susceptibility in lupus nephritis.
    Song K; Liu L; Zhang X; Chen X
    Clin Immunol; 2020 Jan; 210():108272. PubMed ID: 31683055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetics of human lupus nephritis.
    Iwamoto T; Niewold TB
    Clin Immunol; 2017 Dec; 185():32-39. PubMed ID: 27693588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcineurin and Systemic Lupus Erythematosus: The Rationale for Using Calcineurin Inhibitors in the Treatment of Lupus Nephritis.
    Rafael-Vidal C; Altabás I; Pérez N; Mourino Rodríguez C; Pego-Reigosa JM; Garcia S
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33514066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical application of protein biomarkers in lupus erythematosus and lupus nephritis.
    Qi S; Chen Q; Xu D; Xie N; Dai Y
    Lupus; 2018 Sep; 27(10):1582-1590. PubMed ID: 29720035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic factors predisposing to systemic lupus erythematosus and lupus nephritis.
    Ramos PS; Brown EE; Kimberly RP; Langefeld CD
    Semin Nephrol; 2010 Mar; 30(2):164-76. PubMed ID: 20347645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome transcription and DNA methylation analysis of peripheral blood mononuclear cells identified aberrant gene regulation pathways in systemic lupus erythematosus.
    Zhu H; Mi W; Luo H; Chen T; Liu S; Raman I; Zuo X; Li QZ
    Arthritis Res Ther; 2016 Jul; 18():162. PubMed ID: 27412348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DRB1
    Selvaraja M; Chin VK; Abdullah M; Arip M; Amin-Nordin S
    Front Med (Lausanne); 2020; 7():598665. PubMed ID: 33644084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetics of Lupus Nephritis: Clinical Implications.
    Munroe ME; James JA
    Semin Nephrol; 2015 Sep; 35(5):396-409. PubMed ID: 26573543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phoenix from the flames: Rediscovering the role of the CD40-CD40L pathway in systemic lupus erythematosus and lupus nephritis.
    Ramanujam M; Steffgen J; Visvanathan S; Mohan C; Fine JS; Putterman C
    Autoimmun Rev; 2020 Nov; 19(11):102668. PubMed ID: 32942031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal-infiltrating CD11c
    Liao X; Ren J; Reihl A; Pirapakaran T; Sreekumar B; Cecere TE; Reilly CM; Luo XM
    Clin Exp Immunol; 2017 Nov; 190(2):187-200. PubMed ID: 28722110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble TNF-R1, VEGF and other cytokines as markers of disease activity in systemic lupus erythematosus and lupus nephritis.
    Adhya Z; El Anbari M; Anwar S; Mortimer A; Marr N; Karim MY
    Lupus; 2019 May; 28(6):713-721. PubMed ID: 31046570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-32γ: Possible association with the activity and development of nephritis in patients with systemic lupus erythematosus.
    Kwon OC; Ghang B; Lee EJ; Hong S; Lee CK; Yoo B; Kim S; Kim YG
    Int J Rheum Dis; 2019 Jul; 22(7):1305-1311. PubMed ID: 30941928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.
    Mohan C; Putterman C
    Nat Rev Nephrol; 2015 Jun; 11(6):329-41. PubMed ID: 25825084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis.
    Mistry P; Kaplan MJ
    Clin Immunol; 2017 Dec; 185():59-73. PubMed ID: 27519955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Alterations in Immune Cells of Systemic Lupus Erythematosus and Therapeutic Implications.
    Adams DE; Shao WH
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beta-adducin and sodium-calcium exchanger 1 gene variants are associated with systemic lupus erythematosus and lupus nephritis.
    Ramirez GA; Lanzani C; Bozzolo EP; Zagato L; Citterio L; Casamassima N; Canti V; Sabbadini MG; Rovere-Querini P; Manunta P; Manfredi AA
    Rheumatol Int; 2015 Dec; 35(12):1975-83. PubMed ID: 26045217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression.
    Mahajan A; Amelio J; Gairy K; Kaur G; Levy RA; Roth D; Bass D
    Lupus; 2020 Aug; 29(9):1011-1020. PubMed ID: 32571142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of microbiota in the pathogenesis of lupus: Dose it impact lupus nephritis?
    Rahbar Saadat Y; Hejazian M; Bastami M; Hosseinian Khatibi SM; Ardalan M; Zununi Vahed S
    Pharmacol Res; 2019 Jan; 139():191-198. PubMed ID: 30471408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.